Minimal Impact of the Covid-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2B Open-Label Extension Study
AuthID
P-00Y-DW5
P-00Y-DW5